US20200404433A1 - Automatic gain control for implanted microphone - Google Patents
Automatic gain control for implanted microphone Download PDFInfo
- Publication number
- US20200404433A1 US20200404433A1 US16/919,584 US202016919584A US2020404433A1 US 20200404433 A1 US20200404433 A1 US 20200404433A1 US 202016919584 A US202016919584 A US 202016919584A US 2020404433 A1 US2020404433 A1 US 2020404433A1
- Authority
- US
- United States
- Prior art keywords
- output signal
- implanted
- signal
- microphone output
- amplifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims abstract description 34
- 230000000638 stimulation Effects 0.000 claims abstract description 9
- 238000012545 processing Methods 0.000 claims abstract description 5
- 230000003321 amplification Effects 0.000 claims description 15
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 15
- 238000012886 linear function Methods 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 2
- 239000007943 implant Substances 0.000 description 13
- 230000004044 response Effects 0.000 description 13
- 230000006870 function Effects 0.000 description 11
- 210000003625 skull Anatomy 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 8
- 230000001133 acceleration Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 210000000959 ear middle Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000002238 attenuated effect Effects 0.000 description 3
- 210000003477 cochlea Anatomy 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 210000001595 mastoid Anatomy 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 230000001055 chewing effect Effects 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 210000001785 incus Anatomy 0.000 description 2
- 208000032365 Electromagnetic interference Diseases 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 210000003094 ear ossicle Anatomy 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 210000001050 stape Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000000516 tensor tympani Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36036—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of the outer, middle or inner ear
- A61N1/36038—Cochlear stimulation
-
- G—PHYSICS
- G10—MUSICAL INSTRUMENTS; ACOUSTICS
- G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
- G10L25/00—Speech or voice analysis techniques not restricted to a single one of groups G10L15/00 - G10L21/00
- G10L25/78—Detection of presence or absence of voice signals
- G10L25/84—Detection of presence or absence of voice signals for discriminating voice from noise
-
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03G—CONTROL OF AMPLIFICATION
- H03G3/00—Gain control in amplifiers or frequency changers
- H03G3/20—Automatic control
- H03G3/30—Automatic control in amplifiers having semiconductor devices
- H03G3/3005—Automatic control in amplifiers having semiconductor devices in amplifiers suitable for low-frequencies, e.g. audio amplifiers
- H03G3/301—Automatic control in amplifiers having semiconductor devices in amplifiers suitable for low-frequencies, e.g. audio amplifiers the gain being continuously variable
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
- H04R25/00—Deaf-aid sets, i.e. electro-acoustic or electro-mechanical hearing aids; Electric tinnitus maskers providing an auditory perception
- H04R25/35—Deaf-aid sets, i.e. electro-acoustic or electro-mechanical hearing aids; Electric tinnitus maskers providing an auditory perception using translation techniques
- H04R25/356—Amplitude, e.g. amplitude shift or compression
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
- H04R25/00—Deaf-aid sets, i.e. electro-acoustic or electro-mechanical hearing aids; Electric tinnitus maskers providing an auditory perception
- H04R25/50—Customised settings for obtaining desired overall acoustical characteristics
- H04R25/505—Customised settings for obtaining desired overall acoustical characteristics using digital signal processing
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
- H04R25/00—Deaf-aid sets, i.e. electro-acoustic or electro-mechanical hearing aids; Electric tinnitus maskers providing an auditory perception
- H04R25/55—Deaf-aid sets, i.e. electro-acoustic or electro-mechanical hearing aids; Electric tinnitus maskers providing an auditory perception using an external connection, either wireless or wired
- H04R25/556—External connectors, e.g. plugs or modules
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
- H04R25/00—Deaf-aid sets, i.e. electro-acoustic or electro-mechanical hearing aids; Electric tinnitus maskers providing an auditory perception
- H04R25/60—Mounting or interconnection of hearing aid parts, e.g. inside tips, housings or to ossicles
- H04R25/604—Mounting or interconnection of hearing aid parts, e.g. inside tips, housings or to ossicles of acoustic or vibrational transducers
- H04R25/606—Mounting or interconnection of hearing aid parts, e.g. inside tips, housings or to ossicles of acoustic or vibrational transducers acting directly on the eardrum, the ossicles or the skull, e.g. mastoid, tooth, maxillary or mandibular bone, or mechanically stimulating the cochlea, e.g. at the oval window
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
- H04R3/00—Circuits for transducers, loudspeakers or microphones
- H04R3/04—Circuits for transducers, loudspeakers or microphones for correcting frequency response
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS
- H04R2225/00—Details of deaf aids covered by H04R25/00, not provided for in any of its subgroups
- H04R2225/67—Implantable hearing aids or parts thereof not covered by H04R25/606
Definitions
- implantable hearing instruments In the class of hearing aid systems generally referred to as implantable hearing instruments, some or all of various hearing augmentation componentry is positioned subcutaneously on, within, or proximate to a patient's skull, typically at locations proximate the mastoid process.
- implantable hearing instruments may be generally divided into two sub-classes, namely semi-implantable and fully implantable.
- a semi-implantable hearing instrument one or more components such as a microphone, signal processor, and transmitter may be externally located to receive, process, and inductively transmit an audio signal to implanted components such as a transducer.
- a transducer typically all of the components, e.g., the microphone, signal processor, and transducer, are located subcutaneously.
- an implantable transducer is utilized to stimulate a component of the patient's auditory system (e.g., auditory ossicles and/or the cochlea).
- one type of implantable transducer includes an electromechanical transducer having a magnetic coil that drives a vibratory actuator.
- the actuator is positioned to interface with and stimulate the ossicular chain of the patient via physical engagement.
- one or more bones of the ossicular chain are made to mechanically vibrate, which causes the ossicular chain to stimulate the cochlea through its natural input, the so-called oval window.
- an implantable microphone may be positioned (e.g., in a surgical procedure) between a patient's skull and skin, for example, at a location rearward and upward of a patient's ear (e.g., in the mastoid region).
- the skin and tissue covering the microphone diaphragm may increase the vibration sensitivity of the instrument to the point where body sounds (e.g., chewing) and the wearer's own voice, conveyed via bone conduction, may saturate internal amplifier, stages and thus lead to distortion.
- the system may produce feedback by picking up and amplifying vibration caused by the stimulation transducer.
- Certain proposed methods intended to mitigate vibration sensitivity may potentially also have an undesired effect on sensitivity to airborne sound as conducted through the skin. It is therefore desirable to have a means of reducing system response to vibration (e.g., caused by biological sources and/or feedback), without affecting sound sensitivity. It is also desired not to introduce excessive noise during the process of reducing the system response to vibration.
- undesirable vibration e.g., non-ambient vibration
- tissue e.g., skull and/or soft tissue
- undesirable vibration carried by the wearer's tissue
- the wearer's tissue e.g., skull and/or soft tissue
- undesirable vibration carried by the wearer's tissue
- the wearer's tissue e.g., skull and/or soft tissue
- operation of a middle ear transducer used with a hearing instrument may create vibration that is transmitted by the skull to the microphone.
- detection and amplification of the vibration can lead to objectionable feedback.
- Unwanted vibration e.g., in the skull or other tissue
- undesired vibrations may be transmitted to the site of the implanted microphone where a component of these undesired vibrations may be received by a microphone diaphragm and amplified.
- Another objective is to map the entire output of a microphone having a relatively larger dynamic range into a signal processor having a relatively smaller dynamic range.
- Yet another objective is to improve the signal-to-noise ratio of an output signal of a microphone, to enhance the sound quality that a patient receives.
- an implantable hearing instrument system is operative to selectively alter/lower the gain of signals that have a magnitude above a predetermined threshold.
- unnaturally large vibrations e.g., due to a patient's own voice
- desired signals so that a patient may experience a more representative sound.
- an implantable hearing instrument system includes an AGC circuit.
- the AGC circuit may be any circuit that adjusts the gain of a signal from a microphone dependent on a characteristic of that signal. For example, the AGC may amplify a signal by a first value when the signal is below a predetermined threshold, and amplify the signal by a second value that is less than the first value when the signal is above the threshold. Additionally, the AGC may apply a non-linear function to the signal, such that larger signals are amplified relatively less than smaller signals.
- an implantable hearing instrument system includes an AGC circuit that amplifies a signal dependent upon the frequency content of the signal.
- the AGC may be configured to reduce the amplification for signals that are above a predetermined threshold and in a predetermined frequency range (e.g., the frequency range of a patient's own voice).
- a predetermined threshold e.g., the frequency range of a patient's own voice
- larger signals that are due to a patient's own voice may be suppressed, while other large signals (e.g., outside the predetermined frequency range) may be unaffected.
- an implantable hearing instrument system includes an AGC circuit that is configured to map the dynamic range of a microphone into the dynamic range of a signal processor. In one embodiment, this is achieved by reducing the gain that is applied by the AGC to relatively large signals (e.g., signals above a predetermined threshold) so that the output signal of the microphone is “compressed.” Additionally, the AGC may be configured to communicate information about the gain applied to the signals to a signal processor, so that the signal processor may account for the gain applied when conditioning the signals to be output to a transducer.
- an implantable hearing instrument is provided that is operative to identify own voice events and dynamically adjust the gain of a microphone input signal provided to a signal processor of the device.
- an output of an accelerometer is monitored to determine an own voice event. If a signal characteristic exceeds a predetermined value, an own voice event is identified and gain applied to a microphone output signal may be reduced.
- an accelerometer output signal is compared to the microphone output signal to determine the own voice event.
- only a predetermined frequency range of the accelerometer output signal is monitored to determine the own voice event.
- a non-linear gain is applied across the frequency range of the microphone output signal.
- an implantable hearing instrument system includes an AGC circuit coupled to a microphone, wherein the microphone is physically separated from the AGC.
- the output signal of the microphone is amplified at a location near the microphone.
- the signal-to-noise ratio may be improved when electromagnetic interferences are present in the coupling between the microphone and the AGC circuit. Additionally, the signal may also be attenuated prior to being fed into the AGC circuit.
- FIG. 1 illustrates a fully implantable hearing instrument.
- FIG. 2 illustrates one embodiment of a soft tissue mount of a microphone.
- FIG. 3 illustrates a linear input output curve of one combination of a microphone and DSP.
- FIG. 4 illustrates a block diagram of one embodiment of a fully implantable hearing instrument.
- FIG. 5 illustrates a non-linear gain input output curve of one embodiment of a fully implantable hearing instrument.
- FIG. 6 illustrates a block diagram of another embodiment of a fully implantable hearing instrument.
- FIG. 7 illustrates a non-linear gain input output curve of another embodiment of a fully implantable hearing instrument.
- FIG. 8 illustrates a microphone and accelerometer for use in identifying own voice events.
- FIGS. 1 and 2 illustrate one application of the present invention.
- the application comprises a fully implantable hearing instrument system.
- certain aspects of the present invention may be employed in conjunction with semi-implantable hearing instruments as well as other fully implantable hearing instruments (e.g., cochlear implant systems), and therefore the illustrated application is for purposes of illustration and not limitation.
- a biocompatible implant housing 100 is located subcutaneously on a patient's skull.
- the implant housing 100 includes a signal receiver 118 (e.g., comprising a coil element) and is interconnected to a microphone assembly 130 via a signal wire 124 , which is typically a multi-conductor cable.
- the implant housing 100 may be utilized to house a number of components of the implantable hearing instrument.
- the implant housing 100 may house an energy storage device and a signal processor.
- Various additional processing logic and/or circuitry components may also be included in the implant housing 100 as a matter of design choice.
- the signal processor within the implant housing 100 is electrically interconnected via a signal wire 106 to a transducer 108 .
- the transducer 108 is supportably connected to a positioning system 110 , which in turn, is connected to a bone anchor 116 mounted within the patient's mastoid process (e.g., via a hole drilled through the skull).
- the transducer 108 includes a connection apparatus 112 for connecting the transducer 108 to an auditory component of the patient.
- the transducer is connected to the ossicular chain 120 .
- another auditory component e.g., oval window, round window, cochlea, etc.
- connection apparatus 112 provides a communication path for acoustic stimulation of a portion of the ear, such as the ossicles 120 , e.g., through transmission of vibrations to the incus 122 or other ossicles bone.
- the microphone assembly 130 may be spaced from the implant housing 100 such that it need not be mounted to the skull of a patient. Such spacing may facilitate vibration attenuation. Stated otherwise, mounting the microphone assembly 130 relative to soft tissue of the patient may isolate the microphone assembly 130 from one or more sources of non-ambient vibrations (e.g., skull-borne vibrations).
- the microphone assembly 130 includes a diaphragm 132 that is positioned to receive ambient acoustic signals through overlying tissue, a microphone transducer (not shown) for generating an output signal indicative of the received ambient acoustic signals, and a housing 134 for supporting the diaphragm 132 relative to the transducer.
- the wire 124 interconnecting the implant housing 100 and the microphone assembly 130 is routed subcutaneously behind the ear of the patient.
- other microphone assemblies may be utilized including, without limitation, skull mounted microphones and/or microphones that are integrated into the implant housing 100 .
- acoustic signals are received subcutaneously at the diaphragm 132 of the microphone assembly 130 .
- the microphone converts sound pressure levels into proportional electric signals.
- Microphones are generally specified according to the transfer function involved which is commonly on the order of ⁇ 55 dBV/0.1 pa.
- the microphone will usually also include some electrical noise floor and is often specified at its equivalent input noise (EIN).
- EIN equivalent input noise
- the microphone may have an EIN of 25dBSPL. Converting sound pressures to a proportional electrical value requires the following equation:
- dBVout dBSPLin ⁇ (74 dB ⁇ ( ⁇ 55 dBV/0.1 pa))
- 0.1 pa is equivalent to 74dBSPL.
- This is also the electrical equivalent of the stated EIN level in dBV. Therefore, a 25dBSPL EN converts to ⁇ 109 dBV.
- the microphone assembly 130 generates an output signal that is indicative of the received acoustic signals.
- the output signal is provided to the implant housing 100 via the signal wire 124 .
- a signal processor within the implant housing 100 processes the signals to provide a processed audio drive signal via a signal wire 106 to the transducer 108 .
- the signal processor may utilize digital processing techniques to provide frequency shaping, amplification, compression, and other signal conditioning, including conditioning based on patient-specific fitting parameters.
- the audio drive signal causes the transducer 108 to transmit vibrations at acoustic frequencies to the connection apparatus 112 to effect the desired sound sensation via mechanical stimulation of the incus 122 of the patient.
- the dynamic range 205 of the DSP is 80 dB, some portion 210 of the microphone signal must be lost or removed or clipped before the dynamic range of the microphone will “fit” into the DSP. Clipping the microphone signals that are above the maximum input requirement for the DSP will cause distortion and other unwanted sounds to the patient.
- the microphone diaphragm is exposed directly to overlying patient tissue, which creates a mass loading effect.
- This mass loading creates a high sensitivity to mechanical vibrations and other externally induced mechanical movements that deflect the diaphragm and result in large microphone output signals (i.e., electrical signals).
- Such vibrations may be caused by the user's own voice, operation of the implanted transducer, and/or the positional movement of the user. For instance, walking induces a low frequency pulse on the microphone diaphragm and normal daily movements such as showering, hair brushing or simply rubbing/scratching can result in very large output signals.
- Normal vibrations that are induced in the skull due to the users' vocalizations can be mitigated, at least in part, by measuring non-acoustic vibrations with a transducer (e.g., accelerometer, second microphone diaphragm, etc.) and subtracting the transducer signal from the microphone output signal.
- the signal remaining after applying this cancellation technique is proportional to the acoustic sounds that generated the microphone output signal.
- Use of such a cancellation technique is adequate under most normal circumstances. However, in some non-normal circumstances microphone saturation and/or clipping can occur. Such non-normal circumstances include unusually loud vocalizations or external stimulus (e.g., a gunshot).
- the microphone and its amplifier if any, has a large dynamic range and is amplified for normal operation in such a way that the highest expected signal (e.g., normal acoustic levels) arriving from the microphone at the signal processor of the hearing instrument will be near the highest amplitude that signal processor can accept without saturating. This optimizes the available dynamic range of the hearing instrument.
- the highest expected signal e.g., normal acoustic levels
- a hearing aid of any kind has a primary function: to enable the patient to hear and understand speech. This allows the user to participate in everyday human interactions normally. Speech is generally in the range of 55-75dBSPL. It is also useful to hear low level sounds. That is, shuffling papers, the click of a knob, and other such low level sounds are useful auditory feedback and assist in everyday situations. Such low level sounds are generally in the range of 20-30dBSPL. Collectively, these sound levels may be termed useful sound levels.
- Loud sounds are generally above 100dBSPL. Such sounds, while helpful to alert a hearing aid user of environmental conditions, need not be 120dBSPL in order to perform the warning function. To summarize, it is desirable to enhance sounds from about 20dBSPL to about 95dBSPL. Sounds above 95dBSPL have limited utility to the patient and therefore can be selectively reduced as can the unusually loud own voice response some patients encounter. These sound ranges are approximate and it will be appreciated that this range could in either direction for particular applications and requirements.
- a feedback circuit nonlinearly alters the gain of a microphone output signal.
- the system allows for sharp attenuation of gain during non-normal circumstances without attenuating gain during normal circumstances.
- the perceived sound produced by this arrangement is similar to how the inner ear reacts to large amplitude sounds.
- the tensor tympani muscle adds tension to the ossicular chain to muffle vibrations that are being transmitted to the stapes footplate. This is similar in that the effect is essentially an attenuation in the gain of a normal ear.
- the system also allows for mapping the dynamic range of the microphone into the dynamic range of the signal processor to reduce or eliminate clipping.
- FIG. 4 is a block diagram that illustrates an exemplary implantable microphone and hearing instrument system that includes an AGC circuit.
- AGC automatic gain control
- a signal is input to a controllable gain amplifier 164 from an implantable microphone 160 through a conductor 162 .
- the amplifier 164 is operable to amplify the signal received from the implantable microphone 160 by a factor that is dependent upon a control signal the amplifier receives from a gain control voltage node 178 .
- the output of the amplifier 164 is first fed to a detector circuit 170 .
- the detector circuit 170 is operable to sense the magnitude (e.g., a root-mean-square (RMS) value, an absolute value, etc.) of the output signal from the amplifier 164 .
- the detector circuit 170 may then output the sensed value to a subtractor 166 where the signal is subtracted from a reference voltage 168 .
- the output of the subtractor 166 is then fed into the amplifier 164 through the gain control voltage node 178 .
- the gain of the amplifier 164 may be controlled by comparing the output signal on the node 172 with the reference voltage 168 .
- the output signal from the amplifier 164 is also fed through an analog-to-digital (AID) converter 174 , a signal processor 176 , and then to an auditory stimulator, such as the transducer 108 shown in FIG. 1 .
- AID analog-to-digital
- the signal to the DSP 176 branches off from the output of the subtractor 166 prior to reaching the detector 170 in an exemplary embodiment
- FIG. 5 illustrates a transfer function for an exemplary implantable hearing instrument system that includes an AGC circuit, such as the system shown in FIG. 3 .
- the horizontal axis represents the input signal of the amplifier 164 (i.e., the node 162 of FIG. 3 ), while the vertical axis represents the output signal of the amplifier 164 (i.e., the node 172 of FIG. 3 ).
- the gain of the amplifier is a first value (e.g., slope) when the input is below a certain reference level (i.e. the threshold point 208 ), which is indicated by the portion of the line 200 .
- the threshold point 208 is programmably adjustable.
- the gain of the amplifier 164 is reduced to a second value (e.g., slope) that is less than the first value, indicated by the portion of the line 204 that has a slope that is less than the portion of the line 200 .
- this configuration permits very large signals (e.g., unnaturally loud signals due to a patient's own voice) to be amplified at a lower amplification level than smaller signals.
- lowering the amplification for larger signals may permit the full dynamic range 205 of the microphone 160 to “fit” into the dynamic range 206 of the signal processor 176 , which has the effect of reducing distortion, and ultimately producing a higher quality sound for the patient.
- the 110 dB dynamic range of the exemplary microphone may be compressed into the 80 dB dynamic range of the signal processor.
- the transfer function shown in FIG. 5 is a piecewise linear function, those having skill in the art will readily recognize that other functions may be implemented in accordance with the present invention. As an example, a nonlinear transfer function may be used.
- the output of the detector 170 may also be fed to the signal processor 176 .
- This may be desirable so that the signal processor 176 may compensate for the gain that was applied to the signal.
- the signal processor 176 may be able to produce a more representative sound by using the information provided by the output of the detector 170 .
- the detector 170 may also be operable to sense not only the magnitude of the output of the amplifier, but also the frequency content.
- the detector 170 may be configured to sense signals that are in the frequency range of a patient's voice (e.g., 0-4 kHz).
- one or more filters may be used (e.g., a low pass filter positioned between the node 172 and the detector 170 shown in FIG. 3 ).
- a notch filler may be utilized that is set to the upper and lower frequency ranges of a user's voice.
- the AGC may be used primarily to lower the amplification of a patient's own voice, while not affecting the amplification of other larger signals.
- the signal processor 176 may be used to implement the filtering function. For example, in response to an unnaturally loud sound at a relatively narrow frequency (e.g., due to a patient's own voice), the AGC 164 may attenuate, or reduce the amplification of all frequency bands to prevent saturation. When the attenuated signal is then fed to the signal processor 176 , the signal processor 176 may sense the frequency content of the unnaturally loud sound, and correspondingly increase the amplification of other signals outside of that frequency band. In this manner, only signals due to the patient's own voice, or other undesirable signals, are suppressed. As can be appreciated, the AGC function in this embodiment is shared by the AGC hardware 164 and the signal processor 176 .
- FIG. 6 illustrates another block diagram of an exemplary implantable hearing instrument system that includes an AGC circuit.
- the pedant microphone 160 is coupled to the amplifier 164 through a cable 162 .
- the cable 162 may pick up unwanted electromagnetic interference (EMI) signals.
- EMI electromagnetic interference
- the useful signals originating from the microphone can be very small, on the order of, for example, ⁇ 1 m volt. Such small signals can, in some instances, be drown out by EMI interface.
- an amplifier 161 in the pendant enclosure 163 may first amplify the signal from the microphone 160 .
- the difference between the microphone output signals and the EMI noise signals is increased.
- the output signal may also be attenuated prior to being fed to the processor or AGC to prevent saturation. This serves the function of increasing the signal-to-noise ratio (SNR) of the signal that enters the amplifier 164 , which improves the sound quality of the system.
- SNR signal-to-noise ratio
- a non-linear gain functionality may me implemented in another in a standard voltage divider network. That is, a pseudo AGC function can be realized by a variable attenuator instead of utilizing an amplifier. In this method, all signals are optionally amplified first. The resulting signal is then fed to a voltage divider network in which one of the resistors/impedances is varied depending on the signal amplitude or power. A resistor divide network attenuates relatively low signal levels by a small amount and large signal levels by a large amount or vice versa. The input output curve for such a system is illustrated in FIG. 7
- the system may reduce the volume/amplification only in the frequency range of the voice of the user. In such an arrangement, the volume of sounds outside this frequency range are not reduced.
- FIG. 8 illustrates a microphone assembly that is operative to provide a signal indicative of acceleration/vibration that may subsequently be removed from a combined response from a microphone diaphragm, which includes an acceleration response and an ambient sound response.
- the microphone assembly utilizes a first diaphragm 10 that is positioned to be responsive to acoustic signals and acceleration/vibration received through overlying tissue and generate a first output indicative of the acoustic and acceleration signals. More specifically, the microphone diaphragm 10 deflects relative to a first enclosed space. This deflection results in a pressure fluctuation that is monitored by a first microphone element 32 A. Accordingly, the microphone element 32 A generates a first electrical output corresponding to the movement of the microphone diaphragm 10 .
- the microphone assembly also includes a cancellation diaphragm 18 that is mass loaded with a cancellation mass 16 (e.g., proof mass).
- the cancellation diaphragm is a vibration sensitive element (e.g., accelerometer) that is disposed inside of the microphone housing 20 such that it is substantially isolated from ambient acoustic signals.
- the mass loading allows the cancellation diaphragm 18 to deflect in response to acceleration forces applied to the housing 20 .
- the cancellation diaphragm deflects relative to a second enclosed space 30 B in response to acceleration. This deflection results in a pressure fluctuation in the second enclosed space 30 B that is monitored by a second microphone element 32 B.
- the second microphone element 32 B generates a second electrical output corresponding to the movement of the cancellation diaphragm 18 .
- the first microphone diaphragm is directed toward the “wanted” sound.
- the first diaphragm may be disposed towards overlying tissue to receive ambient acoustic sounds.
- the second microphone diaphragm is directed toward an unwanted sound source.
- the second microphone diaphragm may be directed inward to detect the users own voice or other non-ambient vibrations. Both microphone diaphragms may detect both sources of sound but each receives the majority of its signal from the source it is directed toward. This enables the unwanted sound to be subtracted from the wanted or ambient signal. If, however, the unwanted sound becomes sufficiently loud as to dominate both microphones, then the cancellation will no longer faithfully reproduce the speech. Instead it will simply amplify the unwanted sound.
- the AGC circuitry can be utilized such that if the microphones sense essentially the same level of signal and these signals are sufficiently loud then the amplification will be compressed (switched to a lesser amplification mode) under these conditions.
- the output signal of the second microphone diaphragm may be monitored to identify when large amplitude non-ambient signals are present. If the non-ambient signals exceed a predetermined threshold, it may be assumed the user is speaking and the amplification of the input signal may be reduced based on the presumed own voice event. Further, such monitoring (which may be done within the DSP) may be frequency based such that only identified signals within a predetermined frequency range result in a change (e.g., reduction) in amplification.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Signal Processing (AREA)
- Neurosurgery (AREA)
- Multimedia (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Human Computer Interaction (AREA)
- Audiology, Speech & Language Pathology (AREA)
- Computational Linguistics (AREA)
- Prostheses (AREA)
- Computer Networks & Wireless Communication (AREA)
- Electrotherapy Devices (AREA)
Abstract
A method for use in an implantable hearing instrument, including receiving an output signal from an implanted microphone implanted in a person, identifying a first characteristic of said output signal, based on said first characteristic, amplifying said microphone output signal by at least one of a plurality of gain settings to produce an amplified signal, wherein said plurality of gain setting comprise at least two different gain settings, inputting said amplified signal into a signal processor, processing said amplified signal to generate a transducer drive signal; and using said transducer drive signal to drive implanted auditory stimulation device implanted in a person to stimulate an auditory component.
Description
- This application claims the benefit of the filing date of U.S. Provisional Application No. 61/022,390, entitled: “Automated Gain Control for Implanted Microphone,” having a filing date of Jan. 21, 2008, the entire contents of which are incorporated by reference herein.
- In the class of hearing aid systems generally referred to as implantable hearing instruments, some or all of various hearing augmentation componentry is positioned subcutaneously on, within, or proximate to a patient's skull, typically at locations proximate the mastoid process. In this regard, implantable hearing instruments may be generally divided into two sub-classes, namely semi-implantable and fully implantable. In a semi-implantable hearing instrument, one or more components such as a microphone, signal processor, and transmitter may be externally located to receive, process, and inductively transmit an audio signal to implanted components such as a transducer. In a fully implantable hearing instrument, typically all of the components, e.g., the microphone, signal processor, and transducer, are located subcutaneously. In either arrangement, an implantable transducer is utilized to stimulate a component of the patient's auditory system (e.g., auditory ossicles and/or the cochlea).
- By way of example, one type of implantable transducer includes an electromechanical transducer having a magnetic coil that drives a vibratory actuator. The actuator is positioned to interface with and stimulate the ossicular chain of the patient via physical engagement. (See e.g., U.S. Pat. No. 5,702,342). In this regard, one or more bones of the ossicular chain are made to mechanically vibrate, which causes the ossicular chain to stimulate the cochlea through its natural input, the so-called oval window.
- As may be appreciated, a hearing instrument that proposes to utilize an implanted microphone will require that the microphone be positioned at a location that facilitates the receipt of acoustic signals. For such purposes, an implantable microphone may be positioned (e.g., in a surgical procedure) between a patient's skull and skin, for example, at a location rearward and upward of a patient's ear (e.g., in the mastoid region).
- For a wearer a hearing instrument including an implanted microphone (e.g., middle ear transducer or cochlear implant stimulation systems), the skin and tissue covering the microphone diaphragm may increase the vibration sensitivity of the instrument to the point where body sounds (e.g., chewing) and the wearer's own voice, conveyed via bone conduction, may saturate internal amplifier, stages and thus lead to distortion. Also, in systems employing a middle ear stimulation transducer, the system may produce feedback by picking up and amplifying vibration caused by the stimulation transducer.
- Certain proposed methods intended to mitigate vibration sensitivity may potentially also have an undesired effect on sensitivity to airborne sound as conducted through the skin. It is therefore desirable to have a means of reducing system response to vibration (e.g., caused by biological sources and/or feedback), without affecting sound sensitivity. It is also desired not to introduce excessive noise during the process of reducing the system response to vibration. These are the goals of the present invention.
- For a wearer of an implantable hearing instrument (e.g., middle ear or cochlear stimulation systems) that incorporates an implantable microphone, undesirable vibration (e.g., non-ambient vibration) carried by the wearer's tissue (e.g., skull and/or soft tissue) may be detected and amplified by the implantable microphone to an undesirable degree. For instance, operation of a middle ear transducer used with a hearing instrument may create vibration that is transmitted by the skull to the microphone. In this case, detection and amplification of the vibration can lead to objectionable feedback. Unwanted vibration (e.g., in the skull or other tissue) can also arise naturally from talking or chewing. In both cases, undesired vibrations may be transmitted to the site of the implanted microphone where a component of these undesired vibrations may be received by a microphone diaphragm and amplified.
- It is therefore one objective to reduce the response of such hearing instruments to unnaturally high vibrations (e.g., due to a patient's own voice), without necessarily or substantially affecting the response of the microphone to desired signals. Another objective is to map the entire output of a microphone having a relatively larger dynamic range into a signal processor having a relatively smaller dynamic range. Yet another objective is to improve the signal-to-noise ratio of an output signal of a microphone, to enhance the sound quality that a patient receives.
- These and additional objectives are achieved by systems and methods (i.e., utilities) presented herein where an implantable hearing instrument system is operative to selectively alter/lower the gain of signals that have a magnitude above a predetermined threshold. In other words, unnaturally large vibrations (e.g., due to a patient's own voice) are amplified less than desired signals, so that a patient may experience a more representative sound.
- According to one aspect of the present invention, an implantable hearing instrument system is provided that includes an AGC circuit. The AGC circuit may be any circuit that adjusts the gain of a signal from a microphone dependent on a characteristic of that signal. For example, the AGC may amplify a signal by a first value when the signal is below a predetermined threshold, and amplify the signal by a second value that is less than the first value when the signal is above the threshold. Additionally, the AGC may apply a non-linear function to the signal, such that larger signals are amplified relatively less than smaller signals.
- According to a further aspect of the present invention, an implantable hearing instrument system is provided that includes an AGC circuit that amplifies a signal dependent upon the frequency content of the signal. For example, the AGC may be configured to reduce the amplification for signals that are above a predetermined threshold and in a predetermined frequency range (e.g., the frequency range of a patient's own voice). In this regard, larger signals that are due to a patient's own voice may be suppressed, while other large signals (e.g., outside the predetermined frequency range) may be unaffected.
- According to a still further aspect of the present invention, an implantable hearing instrument system is provided that includes an AGC circuit that is configured to map the dynamic range of a microphone into the dynamic range of a signal processor. In one embodiment, this is achieved by reducing the gain that is applied by the AGC to relatively large signals (e.g., signals above a predetermined threshold) so that the output signal of the microphone is “compressed.” Additionally, the AGC may be configured to communicate information about the gain applied to the signals to a signal processor, so that the signal processor may account for the gain applied when conditioning the signals to be output to a transducer.
- According to another aspect of the invention, an implantable hearing instrument is provided that is operative to identify own voice events and dynamically adjust the gain of a microphone input signal provided to a signal processor of the device. In one arrangement an output of an accelerometer is monitored to determine an own voice event. If a signal characteristic exceeds a predetermined value, an own voice event is identified and gain applied to a microphone output signal may be reduced. In one particular arrangement, an accelerometer output signal is compared to the microphone output signal to determine the own voice event. In another arrangement, only a predetermined frequency range of the accelerometer output signal is monitored to determine the own voice event. In a yet further arrangement, a non-linear gain is applied across the frequency range of the microphone output signal.
- According to another aspect of the present invention, an implantable hearing instrument system is provided that includes an AGC circuit coupled to a microphone, wherein the microphone is physically separated from the AGC. In this embodiment, the output signal of the microphone is amplified at a location near the microphone. In this regard, the signal-to-noise ratio may be improved when electromagnetic interferences are present in the coupling between the microphone and the AGC circuit. Additionally, the signal may also be attenuated prior to being fed into the AGC circuit.
-
FIG. 1 illustrates a fully implantable hearing instrument. -
FIG. 2 illustrates one embodiment of a soft tissue mount of a microphone. -
FIG. 3 illustrates a linear input output curve of one combination of a microphone and DSP. -
FIG. 4 illustrates a block diagram of one embodiment of a fully implantable hearing instrument. -
FIG. 5 illustrates a non-linear gain input output curve of one embodiment of a fully implantable hearing instrument. -
FIG. 6 illustrates a block diagram of another embodiment of a fully implantable hearing instrument. -
FIG. 7 illustrates a non-linear gain input output curve of another embodiment of a fully implantable hearing instrument. -
FIG. 8 illustrates a microphone and accelerometer for use in identifying own voice events. - Reference will now be made to the accompanying drawings, which at least assist in illustrating the various pertinent features of the present invention. In this regard, the following description of a hearing aid device is presented for purposes of illustration and description. Furthermore, the description is not intended to limit the invention to the form disclosed herein. Consequently, variations and modifications commensurate with the following teachings, and skill and knowledge of the relevant art, are within the scope of the present invention. The embodiments described herein are further intended to explain the best modes known of practicing the invention and to enable others skilled in the art to utilize the invention in such, or other embodiments and with various modifications required by the particular application(s) or use(s) of the present invention.
-
FIGS. 1 and 2 illustrate one application of the present invention. As illustrated, the application comprises a fully implantable hearing instrument system. As will be appreciated, certain aspects of the present invention may be employed in conjunction with semi-implantable hearing instruments as well as other fully implantable hearing instruments (e.g., cochlear implant systems), and therefore the illustrated application is for purposes of illustration and not limitation. - In the system illustrated in
FIGS. 1 and 2 , abiocompatible implant housing 100 is located subcutaneously on a patient's skull. Theimplant housing 100 includes a signal receiver 118 (e.g., comprising a coil element) and is interconnected to amicrophone assembly 130 via asignal wire 124, which is typically a multi-conductor cable. Theimplant housing 100 may be utilized to house a number of components of the implantable hearing instrument. For instance, theimplant housing 100 may house an energy storage device and a signal processor. Various additional processing logic and/or circuitry components may also be included in theimplant housing 100 as a matter of design choice. In the present arrangement, the signal processor within theimplant housing 100 is electrically interconnected via asignal wire 106 to atransducer 108. - The
transducer 108 is supportably connected to apositioning system 110, which in turn, is connected to abone anchor 116 mounted within the patient's mastoid process (e.g., via a hole drilled through the skull). Thetransducer 108 includes aconnection apparatus 112 for connecting thetransducer 108 to an auditory component of the patient. In the present embodiment, the transducer is connected to theossicular chain 120. However, it will be appreciated that connection to another auditory component (e.g., oval window, round window, cochlea, etc.) is possible and within the scope of the present invention. In a connected state, theconnection apparatus 112 provides a communication path for acoustic stimulation of a portion of the ear, such as theossicles 120, e.g., through transmission of vibrations to theincus 122 or other ossicles bone. - The
microphone assembly 130 may be spaced from theimplant housing 100 such that it need not be mounted to the skull of a patient. Such spacing may facilitate vibration attenuation. Stated otherwise, mounting themicrophone assembly 130 relative to soft tissue of the patient may isolate themicrophone assembly 130 from one or more sources of non-ambient vibrations (e.g., skull-borne vibrations). Themicrophone assembly 130 includes adiaphragm 132 that is positioned to receive ambient acoustic signals through overlying tissue, a microphone transducer (not shown) for generating an output signal indicative of the received ambient acoustic signals, and ahousing 134 for supporting thediaphragm 132 relative to the transducer. As shown, thewire 124 interconnecting theimplant housing 100 and themicrophone assembly 130 is routed subcutaneously behind the ear of the patient. However, it will be appreciated that in other embodiments other microphone assemblies may be utilized including, without limitation, skull mounted microphones and/or microphones that are integrated into theimplant housing 100. - During normal operation, acoustic signals are received subcutaneously at the
diaphragm 132 of themicrophone assembly 130. The microphone converts sound pressure levels into proportional electric signals. Microphones are generally specified according to the transfer function involved which is commonly on the order of −55 dBV/0.1 pa. The microphone will usually also include some electrical noise floor and is often specified at its equivalent input noise (EIN). For example, the microphone may have an EIN of 25dBSPL. Converting sound pressures to a proportional electrical value requires the following equation: -
dBVout=dBSPLin−(74 dB−(−55 dBV/0.1 pa)) - where 0.1 pa is equivalent to 74dBSPL. For example, 25dBSPL converts to 25dBSPL−(74dBSPL+(55 dBV/0.1 pa))=−104 dBV. This is also the electrical equivalent of the stated EIN level in dBV. Therefore, a 25dBSPL EN converts to −109 dBV. This provides the lower limit of the microphone's performance. The upper limit of the microphone is at least 115dBSPL or −19 dBV. This implies a
dynamic range 206 of −109 dBV−(−19 dBV)=90 dB for the microphone. SeeFIG. 3 - The
microphone assembly 130 generates an output signal that is indicative of the received acoustic signals. The output signal is provided to theimplant housing 100 via thesignal wire 124. Upon receipt of the output signal, a signal processor within theimplant housing 100 processes the signals to provide a processed audio drive signal via asignal wire 106 to thetransducer 108. As will be appreciated, the signal processor may utilize digital processing techniques to provide frequency shaping, amplification, compression, and other signal conditioning, including conditioning based on patient-specific fitting parameters. The audio drive signal causes thetransducer 108 to transmit vibrations at acoustic frequencies to theconnection apparatus 112 to effect the desired sound sensation via mechanical stimulation of theincus 122 of the patient. - If the
dynamic range 205 of the DSP is 80 dB, someportion 210 of the microphone signal must be lost or removed or clipped before the dynamic range of the microphone will “fit” into the DSP. Clipping the microphone signals that are above the maximum input requirement for the DSP will cause distortion and other unwanted sounds to the patient. - The microphone diaphragm is exposed directly to overlying patient tissue, which creates a mass loading effect. This mass loading creates a high sensitivity to mechanical vibrations and other externally induced mechanical movements that deflect the diaphragm and result in large microphone output signals (i.e., electrical signals). Such vibrations may be caused by the user's own voice, operation of the implanted transducer, and/or the positional movement of the user. For instance, walking induces a low frequency pulse on the microphone diaphragm and normal daily movements such as showering, hair brushing or simply rubbing/scratching can result in very large output signals.
- Normal vibrations that are induced in the skull due to the users' vocalizations can be mitigated, at least in part, by measuring non-acoustic vibrations with a transducer (e.g., accelerometer, second microphone diaphragm, etc.) and subtracting the transducer signal from the microphone output signal. The signal remaining after applying this cancellation technique is proportional to the acoustic sounds that generated the microphone output signal. Use of such a cancellation technique is adequate under most normal circumstances. However, in some non-normal circumstances microphone saturation and/or clipping can occur. Such non-normal circumstances include unusually loud vocalizations or external stimulus (e.g., a gunshot). In most applications, the microphone and its amplifier, if any, has a large dynamic range and is amplified for normal operation in such a way that the highest expected signal (e.g., normal acoustic levels) arriving from the microphone at the signal processor of the hearing instrument will be near the highest amplitude that signal processor can accept without saturating. This optimizes the available dynamic range of the hearing instrument.
- Unusually large vibrations or other non-normal circumstances produce microphone output signals that are higher than the signal processor can accept. This saturates the input of the signal processor in such a way that no normal acoustic information can be analyzed. One solution to prevent this situation has been to lower the gain of the microphone amplifier such that the output signal cannot saturate the signal processor. However, a reduction of the gain of the microphone output signal may make it difficult for a user to perceive low amplitude acoustic sounds.
- In addition to problems associated with saturation of the signal processor, some patients may experience an unusually loud sound due to vibrations caused by their own voice. For example, some patients may experience a sound that is in the range of 90-110 dB, which is approaching the level of a gunshot. Clearly, this is an undesirable operation for the wearer of an implantable hearing instrument. Again, one remedy is to attenuate the signal from the microphone for all acoustic signals. However, this has drawbacks in speech recognition and/or general sound perception.
- A hearing aid of any kind has a primary function: to enable the patient to hear and understand speech. This allows the user to participate in everyday human interactions normally. Speech is generally in the range of 55-75dBSPL. It is also useful to hear low level sounds. That is, shuffling papers, the click of a knob, and other such low level sounds are useful auditory feedback and assist in everyday situations. Such low level sounds are generally in the range of 20-30dBSPL. Collectively, these sound levels may be termed useful sound levels.
- Loud sounds (e.g., gun shots, hammering, etc.) are generally above 100dBSPL. Such sounds, while helpful to alert a hearing aid user of environmental conditions, need not be 120dBSPL in order to perform the warning function. To summarize, it is desirable to enhance sounds from about 20dBSPL to about 95dBSPL. Sounds above 95dBSPL have limited utility to the patient and therefore can be selectively reduced as can the unusually loud own voice response some patients encounter. These sound ranges are approximate and it will be appreciated that this range could in either direction for particular applications and requirements.
- Presented herein is a system and method for dynamically altering the gain of a microphone output signal to allow for enhancing the gain applied to useful sounds while reducing the gain applied to loud sounds. Generally, a feedback circuit nonlinearly alters the gain of a microphone output signal. The system allows for sharp attenuation of gain during non-normal circumstances without attenuating gain during normal circumstances. The perceived sound produced by this arrangement is similar to how the inner ear reacts to large amplitude sounds. In a normal hearing person, the tensor tympani muscle adds tension to the ossicular chain to muffle vibrations that are being transmitted to the stapes footplate. This is similar in that the effect is essentially an attenuation in the gain of a normal ear. The system also allows for mapping the dynamic range of the microphone into the dynamic range of the signal processor to reduce or eliminate clipping.
- In one embodiment, the gain of the hearing system is dynamically varied by an automatic gain control (AGC) circuit, which automatically adjusts the gain of an amplifier based on a characteristic of an input signal:
FIG. 4 is a block diagram that illustrates an exemplary implantable microphone and hearing instrument system that includes an AGC circuit. In operation, a signal is input to acontrollable gain amplifier 164 from animplantable microphone 160 through aconductor 162. Theamplifier 164 is operable to amplify the signal received from theimplantable microphone 160 by a factor that is dependent upon a control signal the amplifier receives from a gaincontrol voltage node 178. To form the control signal, the output of theamplifier 164 is first fed to adetector circuit 170. Thedetector circuit 170 is operable to sense the magnitude (e.g., a root-mean-square (RMS) value, an absolute value, etc.) of the output signal from theamplifier 164. Thedetector circuit 170 may then output the sensed value to asubtractor 166 where the signal is subtracted from areference voltage 168. The output of thesubtractor 166 is then fed into theamplifier 164 through the gaincontrol voltage node 178. In this regard, the gain of theamplifier 164 may be controlled by comparing the output signal on thenode 172 with thereference voltage 168. The output signal from theamplifier 164 is also fed through an analog-to-digital (AID)converter 174, asignal processor 176, and then to an auditory stimulator, such as thetransducer 108 shown inFIG. 1 . As indicated byreference numeral 169, the signal to theDSP 176 branches off from the output of thesubtractor 166 prior to reaching thedetector 170 in an exemplary embodiment -
FIG. 5 illustrates a transfer function for an exemplary implantable hearing instrument system that includes an AGC circuit, such as the system shown inFIG. 3 . The horizontal axis represents the input signal of the amplifier 164 (i.e., thenode 162 ofFIG. 3 ), while the vertical axis represents the output signal of the amplifier 164 (i.e., thenode 172 ofFIG. 3 ). As can be seen, the gain of the amplifier is a first value (e.g., slope) when the input is below a certain reference level (i.e. the threshold point 208), which is indicated by the portion of theline 200. In one arrangement, thethreshold point 208 is programmably adjustable. When the input is greater than thethreshold point 208, the gain of theamplifier 164 is reduced to a second value (e.g., slope) that is less than the first value, indicated by the portion of theline 204 that has a slope that is less than the portion of theline 200. As can be appreciated, this configuration permits very large signals (e.g., unnaturally loud signals due to a patient's own voice) to be amplified at a lower amplification level than smaller signals. Furthermore, lowering the amplification for larger signals may permit the fulldynamic range 205 of themicrophone 160 to “fit” into thedynamic range 206 of thesignal processor 176, which has the effect of reducing distortion, and ultimately producing a higher quality sound for the patient. For instance, the 110 dB dynamic range of the exemplary microphone may be compressed into the 80 dB dynamic range of the signal processor. Although the transfer function shown inFIG. 5 is a piecewise linear function, those having skill in the art will readily recognize that other functions may be implemented in accordance with the present invention. As an example, a nonlinear transfer function may be used. - As shown in
FIG. 3 , the output of thedetector 170 may also be fed to thesignal processor 176. This may be desirable so that thesignal processor 176 may compensate for the gain that was applied to the signal. In this regard, thesignal processor 176 may be able to produce a more representative sound by using the information provided by the output of thedetector 170. - The
detector 170 may also be operable to sense not only the magnitude of the output of the amplifier, but also the frequency content. For example, thedetector 170 may be configured to sense signals that are in the frequency range of a patient's voice (e.g., 0-4 kHz). To achieve this, one or more filters may be used (e.g., a low pass filter positioned between thenode 172 and thedetector 170 shown inFIG. 3 ). In one arrangement, a notch filler may be utilized that is set to the upper and lower frequency ranges of a user's voice. In this regard, the AGC may be used primarily to lower the amplification of a patient's own voice, while not affecting the amplification of other larger signals. - In another embodiment, the
signal processor 176 may be used to implement the filtering function. For example, in response to an unnaturally loud sound at a relatively narrow frequency (e.g., due to a patient's own voice), theAGC 164 may attenuate, or reduce the amplification of all frequency bands to prevent saturation. When the attenuated signal is then fed to thesignal processor 176, thesignal processor 176 may sense the frequency content of the unnaturally loud sound, and correspondingly increase the amplification of other signals outside of that frequency band. In this manner, only signals due to the patient's own voice, or other undesirable signals, are suppressed. As can be appreciated, the AGC function in this embodiment is shared by theAGC hardware 164 and thesignal processor 176. -
FIG. 6 illustrates another block diagram of an exemplary implantable hearing instrument system that includes an AGC circuit. Various components that are common to those discussed in reference toFIG. 3 are numbered alike. Accordingly, only differences in the present system are discussed herein. In this embodiment, thepedant microphone 160 is coupled to theamplifier 164 through acable 162. Thecable 162 may pick up unwanted electromagnetic interference (EMI) signals. The useful signals originating from the microphone can be very small, on the order of, for example, <1 m volt. Such small signals can, in some instances, be drown out by EMI interface. To reduce the effect of these unwanted signals, anamplifier 161 in thependant enclosure 163 may first amplify the signal from themicrophone 160. By amplifying the signal prior to it leaving thependant enclosure 163, the difference between the microphone output signals and the EMI noise signals is increased. Furthermore, the output signal may also be attenuated prior to being fed to the processor or AGC to prevent saturation. This serves the function of increasing the signal-to-noise ratio (SNR) of the signal that enters theamplifier 164, which improves the sound quality of the system. - In an alternate arrangement, a non-linear gain functionality may me implemented in another in a standard voltage divider network. That is, a pseudo AGC function can be realized by a variable attenuator instead of utilizing an amplifier. In this method, all signals are optionally amplified first. The resulting signal is then fed to a voltage divider network in which one of the resistors/impedances is varied depending on the signal amplitude or power. A resistor divide network attenuates relatively low signal levels by a small amount and large signal levels by a large amount or vice versa. The input output curve for such a system is illustrated in
FIG. 7 - As noted above, it is sometimes desirable to cancel noise signals form the microphone output signal. Generally a vibration response of an accelerometer is matched to the vibration response of the microphone to achieve cancellation. The cancellation compares the signal of the microphone and accelerometer and attempts to cancel any common signals. An example of such a system is set forth in U.S. patent Ser. No. 11/565,001 entitled “Dual Feedback Control System For Implantable Hearing Instrument” the entire contents of which are incorporated herein by reference. Own voice however, will be a common signal and under some conditions (e.g., patient dependent) will be greater than the airborne sound. The airborne sound will contain essentially the same content, own voice, as the vibration signal. The algorithm may not be able to distinguish between the airborne and tissue borne. It may be necessary to sense the presence of own voice and reduce the signal level input into the DSP. The patient would then hear his own voice at a reduced volume and consequently all other sounds will be reduced. Alternatively, the system may reduce the volume/amplification only in the frequency range of the voice of the user. In such an arrangement, the volume of sounds outside this frequency range are not reduced.
-
FIG. 8 illustrates a microphone assembly that is operative to provide a signal indicative of acceleration/vibration that may subsequently be removed from a combined response from a microphone diaphragm, which includes an acceleration response and an ambient sound response. As shown, the microphone assembly utilizes afirst diaphragm 10 that is positioned to be responsive to acoustic signals and acceleration/vibration received through overlying tissue and generate a first output indicative of the acoustic and acceleration signals. More specifically, themicrophone diaphragm 10 deflects relative to a first enclosed space. This deflection results in a pressure fluctuation that is monitored by a first microphone element 32A. Accordingly, the microphone element 32A generates a first electrical output corresponding to the movement of themicrophone diaphragm 10. - The microphone assembly also includes a
cancellation diaphragm 18 that is mass loaded with a cancellation mass 16 (e.g., proof mass). The cancellation diaphragm is a vibration sensitive element (e.g., accelerometer) that is disposed inside of themicrophone housing 20 such that it is substantially isolated from ambient acoustic signals. The mass loading allows thecancellation diaphragm 18 to deflect in response to acceleration forces applied to thehousing 20. Specifically, the cancellation diaphragm deflects relative to a second enclosed space 30B in response to acceleration. This deflection results in a pressure fluctuation in the second enclosed space 30B that is monitored by a second microphone element 32B. Accordingly, the second microphone element 32B generates a second electrical output corresponding to the movement of thecancellation diaphragm 18. - Generally, the first microphone diaphragm is directed toward the “wanted” sound. For example, the first diaphragm may be disposed towards overlying tissue to receive ambient acoustic sounds. The second microphone diaphragm is directed toward an unwanted sound source. For example, the second microphone diaphragm may be directed inward to detect the users own voice or other non-ambient vibrations. Both microphone diaphragms may detect both sources of sound but each receives the majority of its signal from the source it is directed toward. This enables the unwanted sound to be subtracted from the wanted or ambient signal. If, however, the unwanted sound becomes sufficiently loud as to dominate both microphones, then the cancellation will no longer faithfully reproduce the speech. Instead it will simply amplify the unwanted sound. Such an arrangement is possible if the users own voice dominates both microphones. In this situation, the AGC circuitry can be utilized such that if the microphones sense essentially the same level of signal and these signals are sufficiently loud then the amplification will be compressed (switched to a lesser amplification mode) under these conditions.
- In an alternate arrangement, the output signal of the second microphone diaphragm (or other accelerometer) may be monitored to identify when large amplitude non-ambient signals are present. If the non-ambient signals exceed a predetermined threshold, it may be assumed the user is speaking and the amplification of the input signal may be reduced based on the presumed own voice event. Further, such monitoring (which may be done within the DSP) may be frequency based such that only identified signals within a predetermined frequency range result in a change (e.g., reduction) in amplification.
- While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description is to be considered as exemplary and not restrictive in character. For example, certain embodiments described hereinabove may be combinable with other described embodiments and/or arranged in other ways (e.g., process elements may be performed in other sequences). Accordingly, it should be understood that only the preferred embodiment and variants thereof have been shown and described and that all changes and modifications that come within the spirit of the invention are desired to be protected.
Claims (20)
1. A method for use in an implantable hearing instrument, comprising:
receiving an output signal from an implanted transducer implanted in a person;
identifying a first characteristic of said output signal from the implanted transducer;
based on said first characteristic, amplifying an implanted microphone output signal by at least one of a plurality of gain settings to produce an amplified signal;
inputting said amplified signal into a signal processor; and
processing said amplified signal to generate a transducer drive signal.
2. The method of claim 1 , wherein:
the transducer is the implanted microphone, and the output signal from the implanted transducer is the implanted microphone output signal.
3. The method of claim 2 , wherein identifying said first characteristic comprises:
identifying a magnitude of said implanted microphone output signal.
4. The method of claim 3 , further comprising:
identifying a magnitude of a predetermined frequency range of said implanted microphone output signal.
5. The method of claim 2 , wherein amplifying comprises:
utilizing a non-linear function to amplify said implanted microphone output signal.
6. The method of claim 2 , wherein the action of amplifying comprises:
amplifying a first frequency portion of said implanted microphone output signal associated with a voice of the person using a first gain setting and amplifying at least a second frequency portion of said implanted microphone output signal with a second gain setting, where said second gain setting is larger than said first gain setting.
7. The method of claim 2 , wherein the action of amplifying comprises compressing an output range of said implanted microphone output signal.
8. The method of claim 2 , wherein the action of identifying the first characteristic includes identifying a characteristic indicative of an own voice event as differentiated from a characteristic indicative of other types of body noise.
9. The method of claim 2 , wherein said plurality of gain settings comprise at least two different gain settings.
10. The method of claim 2 , further comprising:
using said transducer drive signal to drive an implanted auditory stimulation device implanted in a person to stimulate an auditory component.
11. The method of claim 2 , wherein said plurality of gain settings comprise at least two different gain settings, the method further comprising:
using said transducer drive signal to drive an implanted auditory stimulation device implanted in a person to stimulate an auditory component.
12. The method of claim 2 , wherein the action of amplifying the implanted microphone output signal is executed using an amplifier, the method further comprises adjusting a gain setting of the amplifier by the at least one of the plurality of gain settings.
13. The method of claim 12 , further comprising subsequent to the action of processing said amplified signal, determining that the first characteristic is not present in a subsequently received implanted microphone output signal, and subsequently amplifying the subsequently received implanted microphone output signal by another of the plurality of gain settings different from the at least one of the plurality of gain settings based on the subsequent determination.
14. The method of claim 2 , wherein:
the action of amplifying said implanted microphone output signal includes amplifying first frequencies of the implanted microphone output signal less than second frequencies of the implanted microphone output signal, wherein the second frequencies are different than the first frequencies.
15. The method of claim 14 wherein:
the first frequencies correspond to frequencies of the person's own voice received by the microphone.
16. The method of claim 2 , wherein:
the action of amplifying the implanted microphone output signal includes reducing a gain setting of the hearing instrument relative to that which was the case prior to the identification of the first characteristic.
17. The method of claim 2 , wherein:
the action of amplifying the implanted microphone output signal includes amplifying a first frequency portion of said implanted microphone output signal associated with a voice of the person using a first gain setting of the plurality of gain settings and amplifying at least a second frequency portion of said implanted microphone output signal with a second gain setting of the plurality of gain settings, the second gain setting being different from the first gain setting, where said second gain setting is larger than said first gain setting.
18. The method of claim 2 , wherein identifying a first characteristic comprises:
monitoring a predetermined frequency band of said implanted microphone output signal.
19. The method of claim 18 , wherein:
the action of amplifying the microphone results in a reduction in the amplification of the frequencies of the monitored frequency band relative to other frequencies of the microphone output signal.
20. The method of claim 1 , wherein:
the transducer is an accelerometer, and thus the output signal received from the implanted transducer is different from the implanted microphone output signal.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/919,584 US20200404433A1 (en) | 2008-01-21 | 2020-07-02 | Automatic gain control for implanted microphone |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2239008P | 2008-01-21 | 2008-01-21 | |
US12/357,183 US8641595B2 (en) | 2008-01-21 | 2009-01-21 | Automatic gain control for implanted microphone |
US14/171,647 US9420384B2 (en) | 2008-01-21 | 2014-02-03 | Automatic gain control for implanted microphone |
US15/229,413 US20160345108A1 (en) | 2008-01-21 | 2016-08-05 | Automatic gain control for implanted microphone |
US16/919,584 US20200404433A1 (en) | 2008-01-21 | 2020-07-02 | Automatic gain control for implanted microphone |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/229,413 Continuation US20160345108A1 (en) | 2008-01-21 | 2016-08-05 | Automatic gain control for implanted microphone |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200404433A1 true US20200404433A1 (en) | 2020-12-24 |
Family
ID=40877002
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/357,183 Active 2032-11-17 US8641595B2 (en) | 2008-01-21 | 2009-01-21 | Automatic gain control for implanted microphone |
US14/171,647 Active US9420384B2 (en) | 2008-01-21 | 2014-02-03 | Automatic gain control for implanted microphone |
US15/229,413 Abandoned US20160345108A1 (en) | 2008-01-21 | 2016-08-05 | Automatic gain control for implanted microphone |
US16/919,584 Pending US20200404433A1 (en) | 2008-01-21 | 2020-07-02 | Automatic gain control for implanted microphone |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/357,183 Active 2032-11-17 US8641595B2 (en) | 2008-01-21 | 2009-01-21 | Automatic gain control for implanted microphone |
US14/171,647 Active US9420384B2 (en) | 2008-01-21 | 2014-02-03 | Automatic gain control for implanted microphone |
US15/229,413 Abandoned US20160345108A1 (en) | 2008-01-21 | 2016-08-05 | Automatic gain control for implanted microphone |
Country Status (2)
Country | Link |
---|---|
US (4) | US8641595B2 (en) |
WO (1) | WO2009094390A2 (en) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2464029A1 (en) | 2004-04-08 | 2005-10-08 | Valery Telfort | Non-invasive ventilation monitor |
US8641595B2 (en) | 2008-01-21 | 2014-02-04 | Cochlear Limited | Automatic gain control for implanted microphone |
US9107625B2 (en) | 2008-05-05 | 2015-08-18 | Masimo Corporation | Pulse oximetry system with electrical decoupling circuitry |
US8771204B2 (en) | 2008-12-30 | 2014-07-08 | Masimo Corporation | Acoustic sensor assembly |
US8771166B2 (en) | 2009-05-29 | 2014-07-08 | Cochlear Limited | Implantable auditory stimulation system and method with offset implanted microphones |
WO2011047216A2 (en) | 2009-10-15 | 2011-04-21 | Masimo Corporation | Physiological acoustic monitoring system |
US8715206B2 (en) | 2009-10-15 | 2014-05-06 | Masimo Corporation | Acoustic patient sensor |
US8790268B2 (en) * | 2009-10-15 | 2014-07-29 | Masimo Corporation | Bidirectional physiological information display |
US9106038B2 (en) * | 2009-10-15 | 2015-08-11 | Masimo Corporation | Pulse oximetry system with low noise cable hub |
US8821415B2 (en) | 2009-10-15 | 2014-09-02 | Masimo Corporation | Physiological acoustic monitoring system |
US8430817B1 (en) | 2009-10-15 | 2013-04-30 | Masimo Corporation | System for determining confidence in respiratory rate measurements |
US9724016B1 (en) | 2009-10-16 | 2017-08-08 | Masimo Corp. | Respiration processor |
EP2352312B1 (en) * | 2009-12-03 | 2013-07-31 | Oticon A/S | A method for dynamic suppression of surrounding acoustic noise when listening to electrical inputs |
WO2011069122A1 (en) | 2009-12-04 | 2011-06-09 | Masimo Corporation | Calibration for multi-stage physiological monitors |
US9307928B1 (en) | 2010-03-30 | 2016-04-12 | Masimo Corporation | Plethysmographic respiration processor |
US9326712B1 (en) | 2010-06-02 | 2016-05-03 | Masimo Corporation | Opticoustic sensor |
US20120136197A1 (en) * | 2010-11-30 | 2012-05-31 | Van Gerwen Peter B J | Hearing prosthesis having a flexible elongate energy transfer mechanism |
EP2687024A2 (en) * | 2011-03-17 | 2014-01-22 | Advanced Bionics AG | Implantable microphone |
JP5872687B2 (en) * | 2011-06-01 | 2016-03-01 | エプコス アーゲーEpcos Ag | Assembly comprising an analog data processing unit and method of using the assembly |
US20130018218A1 (en) * | 2011-07-14 | 2013-01-17 | Sophono, Inc. | Systems, Devices, Components and Methods for Bone Conduction Hearing Aids |
US9192351B1 (en) | 2011-07-22 | 2015-11-24 | Masimo Corporation | Acoustic respiratory monitoring sensor with probe-off detection |
US9537460B2 (en) * | 2011-07-22 | 2017-01-03 | Continental Automotive Systems, Inc. | Apparatus and method for automatic gain control |
EP3603502B1 (en) | 2011-10-13 | 2023-10-04 | Masimo Corporation | Physiological acoustic monitoring system |
US9955937B2 (en) | 2012-09-20 | 2018-05-01 | Masimo Corporation | Acoustic patient sensor coupler |
US9319150B2 (en) * | 2012-10-29 | 2016-04-19 | Dell Products, Lp | Reduction of haptic noise feedback in system |
US9560444B2 (en) * | 2013-03-13 | 2017-01-31 | Cisco Technology, Inc. | Kinetic event detection in microphones |
US10441181B1 (en) | 2013-03-13 | 2019-10-15 | Masimo Corporation | Acoustic pulse and respiration monitoring system |
US10828007B1 (en) | 2013-10-11 | 2020-11-10 | Masimo Corporation | Acoustic sensor with attachment portion |
US10257619B2 (en) * | 2014-03-05 | 2019-04-09 | Cochlear Limited | Own voice body conducted noise management |
US10525265B2 (en) | 2014-12-09 | 2020-01-07 | Cochlear Limited | Impulse noise management |
US9782586B2 (en) * | 2015-08-27 | 2017-10-10 | iMEDI PLUS Inc. | Signal processing method in cochlear implant |
US10321247B2 (en) | 2015-11-27 | 2019-06-11 | Cochlear Limited | External component with inductance and mechanical vibratory functionality |
US11071869B2 (en) | 2016-02-24 | 2021-07-27 | Cochlear Limited | Implantable device having removable portion |
US9937346B2 (en) * | 2016-04-26 | 2018-04-10 | Cochlear Limited | Downshifting of output in a sense prosthesis |
WO2018085328A2 (en) * | 2016-11-01 | 2018-05-11 | Med-El Elektromedizinische Geraete Gmbh | Adaptive noise cancelling of bone conducted noise in the mechanical domain |
US10277183B2 (en) | 2017-03-14 | 2019-04-30 | Sorenson Ip Holdings, Llc | Volume-dependent automatic gain control |
US10463476B2 (en) | 2017-04-28 | 2019-11-05 | Cochlear Limited | Body noise reduction in auditory prostheses |
CN111937411B (en) | 2018-04-04 | 2022-07-05 | 科利耳有限公司 | System and method for adaptive calibration of a subcutaneous microphone |
US10523170B1 (en) * | 2018-09-05 | 2019-12-31 | Amazon Technologies, Inc. | Audio signal processing for motion detection |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7031484B2 (en) * | 2001-04-13 | 2006-04-18 | Widex A/S | Suppression of perceived occlusion |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4630302A (en) * | 1985-08-02 | 1986-12-16 | Acousis Company | Hearing aid method and apparatus |
DK0567535T3 (en) * | 1991-01-17 | 2003-12-08 | Roger A Adelman | Improved hearing aid |
US7489790B2 (en) * | 2000-12-05 | 2009-02-10 | Ami Semiconductor, Inc. | Digital automatic gain control |
AUPR438601A0 (en) * | 2001-04-11 | 2001-05-17 | Cochlear Limited | Variable sensitivity control for a cochlear implant |
US7197152B2 (en) | 2002-02-26 | 2007-03-27 | Otologics Llc | Frequency response equalization system for hearing aid microphones |
US20050101830A1 (en) | 2003-11-07 | 2005-05-12 | Easter James R. | Implantable hearing aid transducer interface |
US7556597B2 (en) | 2003-11-07 | 2009-07-07 | Otologics, Llc | Active vibration attenuation for implantable microphone |
US7214179B2 (en) | 2004-04-01 | 2007-05-08 | Otologics, Llc | Low acceleration sensitivity microphone |
EP2624597B1 (en) | 2005-01-11 | 2014-09-10 | Cochlear Limited | Implantable hearing system |
US8550977B2 (en) | 2005-02-16 | 2013-10-08 | Cochlear Limited | Integrated implantable hearing device, microphone and power unit |
US7354394B2 (en) | 2005-06-20 | 2008-04-08 | Otologics, Llc | Soft tissue placement of implantable microphone |
US7489793B2 (en) | 2005-07-08 | 2009-02-10 | Otologics, Llc | Implantable microphone with shaped chamber |
US7429943B2 (en) | 2005-11-29 | 2008-09-30 | Cochlear Limited | Analog to digital (A/D) conversion circuit have a low dynamic range A/D converter |
US7522738B2 (en) | 2005-11-30 | 2009-04-21 | Otologics, Llc | Dual feedback control system for implantable hearing instrument |
US20070282392A1 (en) | 2006-05-30 | 2007-12-06 | Phonak Ag | Method and system for providing hearing assistance to a user |
US8641595B2 (en) | 2008-01-21 | 2014-02-04 | Cochlear Limited | Automatic gain control for implanted microphone |
-
2009
- 2009-01-21 US US12/357,183 patent/US8641595B2/en active Active
- 2009-01-21 WO PCT/US2009/031581 patent/WO2009094390A2/en active Application Filing
-
2014
- 2014-02-03 US US14/171,647 patent/US9420384B2/en active Active
-
2016
- 2016-08-05 US US15/229,413 patent/US20160345108A1/en not_active Abandoned
-
2020
- 2020-07-02 US US16/919,584 patent/US20200404433A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7031484B2 (en) * | 2001-04-13 | 2006-04-18 | Widex A/S | Suppression of perceived occlusion |
Also Published As
Publication number | Publication date |
---|---|
US20140221729A1 (en) | 2014-08-07 |
US9420384B2 (en) | 2016-08-16 |
WO2009094390A3 (en) | 2009-10-29 |
US20090187065A1 (en) | 2009-07-23 |
US20160345108A1 (en) | 2016-11-24 |
US8641595B2 (en) | 2014-02-04 |
WO2009094390A2 (en) | 2009-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200404433A1 (en) | Automatic gain control for implanted microphone | |
US11706572B2 (en) | Prosthesis state and feedback path based parameter management | |
US6496734B1 (en) | Auditory prosthesis with automated voice muting using the stapedius muscle reflex | |
US7775964B2 (en) | Active vibration attenuation for implantable microphone | |
US10375485B2 (en) | Hearing device comprising a microphone control system | |
US7522738B2 (en) | Dual feedback control system for implantable hearing instrument | |
EP3115079B1 (en) | Signal processor for a hearing device | |
US10111017B2 (en) | Control techniques based on own voice related phenomena | |
US10306377B2 (en) | Feedback path evaluation based on an adaptive system | |
US11510018B2 (en) | Hearing system containing a hearing instrument and a method for operating the hearing instrument | |
US11523227B2 (en) | System and method for adaptive calibration of subcutaneous microphone | |
EP3113519B1 (en) | Methods and devices for correct and safe placement of an in-ear communication device in the ear canal of a user | |
US10525265B2 (en) | Impulse noise management | |
EP2747454B1 (en) | Separate inner and outer hair cell loss compensation | |
US11722815B2 (en) | Implantable microphone management | |
CN114073817A (en) | Cochlear implant system with improved temporal feature selection | |
CN115702789A (en) | Method for creating an audiogram of a person to be tested by means of a hearing instrument |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |